Subscribe to stay informed!
PhaseBio Pharmaceuticals, a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, has been awarded a $2.8 million grant.
The Fast…
Before we send you to this site, please subscribe to our daily newsletter.